The Effect of Dose Titration and Dose Tapering on the Tolerability of DVS SR in Women With Vasomotor Symptoms Associated With Menopause: The PRIMMUS (PRIstiq for Managing Menopause and Understanding Symptoms) Study.

Trial Profile

The Effect of Dose Titration and Dose Tapering on the Tolerability of DVS SR in Women With Vasomotor Symptoms Associated With Menopause: The PRIMMUS (PRIstiq for Managing Menopause and Understanding Symptoms) Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Desvenlafaxine (Primary)
  • Indications Menopausal syndrome
  • Focus Adverse reactions
  • Acronyms PRIMMUS
  • Most Recent Events

    • 09 May 2011 New trial record
    • 04 May 2011 Results presented at the 59th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top